[{"id":"2d1c3ca8-7296-43e4-82a1-3a09a7010bbd","acronym":"C-SMART","url":"https://clinicaltrials.gov/study/NCT04534725","created_at":"2021-01-18T21:42:26.535Z","updated_at":"2024-07-02T16:35:39.087Z","phase":"Phase 3","brief_title":"COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;","source_id_and_acronym":"NCT04534725 - C-SMART","lead_sponsor":"Peter MacCallum Cancer Centre, Australia","biomarkers":" CRP","pipe":"","alterations":" ","tags":["CRP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xpovio (selinexor) • LENZ (lenzilumab)"],"overall_status":"Completed","enrollment":" Enrollment 441","initiation":"Initiation: 12/17/2020","start_date":" 12/17/2020","primary_txt":" Primary completion: 11/28/2022","primary_completion_date":" 11/28/2022","study_txt":" Completion: 04/19/2023","study_completion_date":" 04/19/2023","last_update_posted":"2023-08-24"},{"id":"2f8e2a07-33dd-409a-8481-6ec0b6528ee1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05760196","created_at":"2023-03-08T17:01:45.795Z","updated_at":"2024-07-02T16:35:53.786Z","phase":"Phase 2","brief_title":"Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors","source_id_and_acronym":"NCT05760196","lead_sponsor":"Xiangpan Li","biomarkers":" CD8","pipe":"","alterations":" ","tags":["CD8"],"overall_status":"Recruiting","enrollment":" Enrollment 56","initiation":"Initiation: 10/01/2022","start_date":" 10/01/2022","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 09/30/2025","study_completion_date":" 09/30/2025","last_update_posted":"2023-03-08"}]